Suppr超能文献

充血性心力衰竭作为胸腔积液病因的意义:来自大型多学科教学医院的初步数据。

Significance of congestive heart failure as a cause of pleural effusion: Pilot data from a large multidisciplinary teaching hospital.

机构信息

Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Poland.

Students' Research Group "Alveolus", Medical University of Warsaw, Poland.

出版信息

Cardiol J. 2020;27(3):254-261. doi: 10.5603/CJ.a2018.0137. Epub 2018 Nov 8.

Abstract

BACKGROUND

Epidemiological data on the causes of pleural effusion (PE) are scarce. Data on the local prevalence of various causes of PE may play a crucial role in the management strategy of patients with PE. The aim of the study was to investigate the causes of PE and to assess 30-day mortality rate in unselected adult patients treated in a large, multidisciplinary hospital.

METHODS

Retrospective analysis of medical records, including chest radiographs, of 2835 consecutive patients admitted to the hospital was performed. Radiograhic signs of PE were found in 195 of 1936 patients in whom chest radigraphs were available. These patients formed the study group.

RESULTS

The leading causes of PE were as follows: congestive heart failure (CHF; 37.4%), pneumonia (19.5%), malignancy (15.4%), liver cirrhosis (4.2%) and pulmonary embolism. The cause of PE in 6.7% patients was not established. There was a significant predominance of small volume PE as compared to a moderate or large volume PEs (153, 28 and 14 patients, respectively). Almost 80% of patients with CHF presented with small volume PE, while almost 50% of patients with malignant PE demonstrated moderate or large volume PE. Thirty-day mortality rate ranged from 0% for tuberculous pleurisy to 40% for malignant PE (MPE).

CONCLUSIONS

Pleural effusion was found in 10.1% of patients treated in a large multidisciplinary hospital. CHF was the leading cause of PE. Although 30-day mortality in patients with CHF was rela-tively high, it was lower than that in parapneumonic PE and MPE.

摘要

背景

关于胸腔积液(PE)病因的流行病学数据很少。有关胸腔积液各种病因的本地患病率的数据可能在胸腔积液患者的管理策略中起关键作用。本研究的目的是调查胸腔积液的病因,并评估在一家大型多学科医院治疗的未选择的成年患者的 30 天死亡率。

方法

对 1936 名有胸片的患者中的 195 名进行了回顾性分析,这些患者的医疗记录包括胸部 X 光片。这些患者构成了研究组。

结果

胸腔积液的主要病因如下:充血性心力衰竭(CHF;37.4%)、肺炎(19.5%)、恶性肿瘤(15.4%)、肝硬化(4.2%)和肺栓塞。6.7%患者的胸腔积液病因未明确。与中量或大量胸腔积液相比,小量胸腔积液明显更为常见(分别为 153、28 和 14 例)。几乎 80%的 CHF 患者出现小量胸腔积液,而几乎 50%的恶性肿瘤患者出现中量或大量胸腔积液。30 天死亡率从结核性胸膜炎的 0%到恶性肿瘤所致的胸腔积液(MPE)的 40%不等。

结论

在一家大型多学科医院治疗的患者中,10.1%发现胸腔积液。CHF 是胸腔积液的主要病因。尽管 CHF 患者的 30 天死亡率相对较高,但低于类肺炎性胸腔积液和 MPE。

相似文献

2
Clinical profile of patients with pleural effusion admitted to KMCTH.
Kathmandu Univ Med J (KUMJ). 2009 Oct-Dec;7(28):438-44. doi: 10.3126/kumj.v7i4.2772.
3
Pleural effusions in the medical ICU: prevalence, causes, and clinical implications.
Chest. 1997 Apr;111(4):1018-23. doi: 10.1378/chest.111.4.1018.
4
Common causes of pleural effusion in referral hospital in Isfahan, Iran 1997-1998.
Asian Cardiovasc Thorac Ann. 2002 Mar;10(1):43-6. doi: 10.1177/021849230201000111.
6
The etiology of pleural effusions in an area with high incidence of tuberculosis.
Chest. 1996 Jan;109(1):158-62. doi: 10.1378/chest.109.1.158.
8
Incidence of pleural effusion in patients with pulmonary embolism.
Chin Med J (Engl). 2015 Apr 20;128(8):1032-6. doi: 10.4103/0366-6999.155073.
9
Pleural effusion in patients with pulmonary embolism.
Respirology. 2008 Nov;13(6):832-6. doi: 10.1111/j.1440-1843.2008.01345.x. Epub 2008 Jul 24.

引用本文的文献

1
Chylothorax After Single-Chamber Implantable Cardioverter-Defibrillator Extraction.
JACC Case Rep. 2025 Jun 4;30(13):103882. doi: 10.1016/j.jaccas.2025.103882.
2
BubR1 Controls Heart Development by Promoting Expression of Cardiogenesis Regulators.
J Am Heart Assoc. 2025 Mar 18;14(6):e038286. doi: 10.1161/JAHA.124.038286. Epub 2025 Mar 7.
3
Chest Tubes and Pleural Drainage: History and Current Status in Pleural Disease Management.
J Clin Med. 2024 Oct 23;13(21):6331. doi: 10.3390/jcm13216331.
7
Effectiveness and Safety of Real-Time Transthoracic Ultrasound-Guided Thoracentesis.
Diagnostics (Basel). 2022 Mar 16;12(3):725. doi: 10.3390/diagnostics12030725.

本文引用的文献

1
Comparison of viral infection in healthcare-associated pneumonia (HCAP) and community-acquired pneumonia (CAP).
PLoS One. 2018 Feb 15;13(2):e0192893. doi: 10.1371/journal.pone.0192893. eCollection 2018.
2
Deaths: Final Data for 2015.
Natl Vital Stat Rep. 2017 Nov;66(6):1-75.
4
Predictive models of malignant transudative pleural effusions.
J Thorac Dis. 2017 Jan;9(1):106-116. doi: 10.21037/jtd.2017.01.12.
5
Advances in the diagnosis of tuberculous pleuritis.
Ann Transl Med. 2016 Aug;4(15):282. doi: 10.21037/atm.2016.07.23.
9
10
Diagnostic performance of different pleural fluid biomarkers in tuberculous pleurisy.
Adv Exp Med Biol. 2015;852:21-30. doi: 10.1007/5584_2014_105.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验